Ignite Creation Date:
2024-05-05 @ 5:31 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00479232
Status:
COMPLETED
Last Update Posted:
2015-09-21
First Post:
2007-05-24
Brief Title:
Phase I Trial of Vorinostat MK-0683 SAHA in Combination With Decitabine in Patients With AML or MDS MK-0683-055 EXT1
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC